RIO DE JANEIRO (Reuters) – Brazil’s health regulator Anvisa authorized on Friday the government biomedical institute Fiocruz to produce domestically the active ingredient for the AstraZeneca vaccine against COVID-19, according to a statement.
(Reporting by Pedro Fonseca, in Rio; Writing by Carolina Mandl; Editing by Chris Reese)
